triumph trial retatrutide approval: FDA status, clinical results, and when it could be available Lilly's triple agonist, retatrutide, delivered

Warning signs of dehydration to watch for Know the signals so you can act early

Concentrated urine from dehydration creates an environment where bacteria thrive

Conclusions Our findings underscore the importance of ensuring that patients treated with GLP-1 based therapies are closely monitored and provided with comprehensive nutrition and lifestyle support to ensure they achieve the best long-term health outcomes

Youve Reached a Natural Set Point Your body has a built-in "set point" a weight range it naturally tries to maintain

The new Medicare GLP-1 Bridge gives eligible Part D beneficiaries access to certain GLP-1 weight-loss medications for $50 per month

Randomised controlled trials have demonstrated statistically significant reductions in visceral adipose tissue (VAT) compared to placebo, with improvements in lipid profiles also reported